Allspring Global Investments Holdings, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$50,743
-99.8%
4,424
-99.6%
0.00%
-100.0%
Q2 2023$28,634,746
-42.2%
1,131,361
-26.4%
0.05%
-43.9%
Q1 2023$49,514,822
+145.1%
1,537,250
+40.4%
0.08%
+141.2%
Q4 2022$20,204,912
+27.7%
1,094,524
+86.7%
0.03%
+21.4%
Q3 2022$15,828,000
+316460.0%
586,275
+151392.2%
0.03%
Q2 2022$5,000
-87.2%
387
-80.7%
0.00%
Q1 2022$39,000
+30.0%
2,005
+6.9%
0.00%
Q4 2021$30,0001,8750.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$121,230,00021.92%
Rhenman & Partners Asset Management AB 220,000$5,808,0000.83%
ArrowMark Colorado Holdings LLC 2,045,862$54,011,0000.67%
Vivo Capital, LLC 77,373$2,043,0000.52%
Ghost Tree Capital, LLC 89,295$2,357,0000.49%
ESSEX INVESTMENT MANAGEMENT CO LLC 124,932$3,298,0000.47%
Polar Capital LLP 1,296,371$34,220,0000.46%
SUFFOLK CAPITAL MANAGEMENT LLC 70,095$1,851,0000.24%
EAM Investors, LLC 33,897$895,0000.15%
PointState Capital LP 438,200$11,568,0000.13%
View complete list of REVANCE THERAPEUTICS INC shareholders